Literature DB >> 19707437

Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL.

Greg Hodge1, Stephen Davis, Michael Rice, Heather Tapp, Ben Saxon, Tamas Revesz.   

Abstract

Drugs used for remission induction therapy for childhood precursor-B acute lymphoblastic leukemia (ALL) are nonselective for malignant cells. Several garlic compounds have been shown to induce apoptosis of cancer cells and to alter lymphocyte function. To investigate the effect of garlic on the apoptosis of ALL cells and lymphocyte immune function, cells from newly diagnosed childhood ALL patients were cultured with several commonly used chemotherapeutic agents and several garlic compounds. Apoptosis, lymphocyte proliferation and T-cell cytokine production were determined using multiparameter flow cytometry. At concentrations of garlic compounds that did not result in significant increases in Annexin V and 7-AAD staining of normal lymphocytes, there was a significant increase in apoptosis of ALL cells with no alteration of T-cell proliferation as determined by CD25/CD69 upregulation or interferongamma, interleukin-2 or tumor necrosis factor-alpha intracellular cytokine production. In contrast, the presence of chemotherapeutic agents resulted in nonselective increases in both lymphocyte and ALL apoptosis and a decrease in T-cell proliferation and cytokine production. In conclusion, we show selective apoptosis of malignant cells by garlic compounds that do not alter T-cell immune function and indicate the potential therapeutic benefit of garlic compounds in the treatment of childhood ALL.

Entities:  

Keywords:  apoptosis; childhood precursor-B acute lymphoblastic leukemia; garlic; immune function; intracellular cytokines

Year:  2008        PMID: 19707437      PMCID: PMC2727784          DOI: 10.2147/btt.s2465

Source DB:  PubMed          Journal:  Biologics        ISSN: 1177-5475


Chemotherapeutic agents used in the treatment of childhood precursor-B acute lymphoblastic leukemia (ALL) have been shown to induce apoptosis of ALL cells in vitro (Rohnghe et al 2001), however, hese drugs also induce apoptosis of normal lymphocytes (Leussink et al 2001). Hence there is a need for therapeutic agents that selectively reduce tumour burden while maintaining viability and immune function of normal cells. The role of dietary compounds such as garlic in cancer prevention and treatment has been widely studied and debated (Lamm and Riggs 2001). There is epidemiological evidence that oral consumption of garlic is effective in reducing the incidence of esophageal and gastric cancers (Takezaki et al 2001). Ajoene, a garlic-derived compound, has recently been shown to inhibit proliferation and induce apoptosis of human leukemia cells and induce apoptosis in myeloblasts from a CML patient in blast crisis (Dirsch et al 1998). Allitridium, another garlic-derived compound, has been used intravenously for over twenty years in China to successfully treat Cryptococcus neoformans and other systemic fungal infections (Davis et al 2003). The aim of this present study was to investigate the effect of garlic and two garlic compounds, ajoene and allitridium, compared with commonly used chemotherapeutic drugs on apoptosis of ALL cells and normal lymphocytes in vitro from newly diagnosed ALL patients. As garlic compounds have been shown to stimulate immune effector cells (Lamm and Riggs 2001) and modulate inflammatory cytokine production (Hodge et al 2002), the effect of garlic compounds and commonly used chemotherapeutic drugs on T-cell function following in vitro culture was also investigated.

Patients and methods

Patient samples

Blood and bone marrow samples were collected into preservative-free heparin from fifteen children presenting with pre-B ALL at the Women’s and Children’s Hospital, Adelaide and 12 age-matched volunteers. Mononuclear cells were isolated by standard density gradient centrifugation and cells resuspended in culture medium consisting of RPMI 1640 with 2 × 103 μmol/L L-glutamine (Gibco-BRL, Sydney, Australia) supplemented with 10% fetal calf serum (FCS; CSL, Sydney, Australia), 100 IU/mL penicillin, 100 μg/mL streptomycin (Gibco BRL) (used for all experiments). These mononuclear cells were used in all subsequent experiments.

Garlic extract

Fresh garlic extract was prepared as previously reported (Davis et al 2003). Garlic extract, Allitridium (Harvest Pharmaceutical Company, Shanghai, China), Ajoene (R.A.C., Venezuela) were diluted to desired protein concentration using culture medium immediately before use. Garlic compounds were used in a range of concentrations in experiments: ajoene (0.0005, 0.005, 0.01, 0.5, 5 μg/mL); allitridium (0.0002, 0.005, 0.02, 0.2, 2.5 μg/mL); garlic extract (0.001, 0.01, 0.1, 1, 10 μg/mL protein).

Chemotherapeutic drugs

Chemotherapeutic drugs commonly used in the treatment of childhood ALL were also diluted with culture medium immediately before use in experiments to a range of concentrations likely achievable in vivo (Holleman et al 2003). Prednisolone (0.08, 0.8, 8, 80, 250 μg/mL) (Pharmacia and Upjohn, Sydney, Australia); L-asparaginase (0.003, 0.03, 0.3, 3, 10 μg/mL) (Kyowa Hakko Kogyo, Tokyo, Japan); vincritine (0.005, 0.05, 0.5, 5, 50 μg/mL) (Mayne Pharma, Mulgrave, Vic, Australia); daunorubicin (0.002, 0.02, 0.2, 2.0, 20 μg/mL) (DBL, Sydney, Australia).

Cell culture assays with drugs for apoptosis measurement

Sensitivity of cells to several garlic compounds and several drugs commonly used in the treatment of childhood were tested by adding 80 μL aliquots of cell suspension (2 × 106 cells/mL) PBMC and/or BMMC to 20 μL of various concentrations of drugs in triplicate round-bottomed 96-well microculture plates. Cultures were incubated in a humidified 5% CO2/95% air atmosphere at 37 °C. At 24, 48, and 72 hrs, cells were resuspended and 100 μL aliquots removed and stained with Annexin V FITC and 7-amino-actinomycin D (7-AAD) (Sigma, Sydney, Australia) as previously reported (Hodge et al 2005a) and analyzed using a FACSCalibur flow cytometer using CELLQUEST software (BD).

Cell culture assays with drugs for T-cell activation

The effect of garlic compounds and drugs used in the treatment of childhood ALL on normal T-cell activation was determined by incubating these compounds with the purified cells for 1 hr in a humidified 5% CO2/95% air atmosphere at 37 °C. Phytohaemmagglutinin (10 μg) (Sigma) was then added to these cell cultures and plates reincubated in a humidified 5% CO2/95% air atmosphere at 37 °C. At 24 hrs, cell cultures were resuspended and 100 μL aliquots removed and stained with 5 μL of CD25 FITC (BD), CD69 PE (BD) and CD3 PC5 (Beckman Coulter) as previously reported (Hodge et al 2001).

Cell culture assays with drugs for intracellular T-cell cytokine production

The effect of garlic compounds and drugs used in the treatment of childhood ALL on T-cell cytokine production was determined by incubating these compounds with the purified cells (prepared as for the apoptosis experiments above) for 4 hrs and plates incubated at room temperature for 4 hrs. Cells were stimulated and intracellular cytokine production performed as previously reported (Hodge et al 2005b).

Results

Effect of drugs on ALL and lymphocyte apoptosis

Annexin V staining of normal lymphocytes from healthy controls and blasts and lymphocytes from ALL patients following 24 hrs culture is shown in Table 1.
Table 1

The percentage of Annexin V positive and 7-AAD positive CD3+ lymphocytes and acute lymphoblastic leukemia cells following culture in the presence of no drugs (Control), 2 μg/mL daunorubicin, 50 μg/mL vincristine, 10 IU/mL L-asparaginase, 250 μg/mL prednisolone, 0.1 μg/mL garlic extract, 0.01 μg/mL ajoene, 0.005 μg/mL allitridium compared with normal healthy control subjects

CD3+ Lymphocytes
Leukemia cells
AnnVCpGp7AADCpGpAnnVCpGp7AADCpGpn
Normal2 ± 24 ± 212
Control2 ± 25 ± 228 ± 1636 ± 215
Garlic2 ± 27 ± 3100 ± 60.000100 ± 40.00015
Ajoene9 ± 40.0308 ± 4100 ± 30.000100 ± 50.00015
Allitrid7 ± 30.0429 ± 30.047100 ± 20.000100 ± 40.00015
Daunorubicin40 ± 110.0000.00069 ± 100.0000.00096 ± 110.00099 ± 40.00015
Vincristine41 ± 140.0000.00048 ± 90.0000.00083 ± 160.0000.04898 ± 60.00015
L-asparaginase23 ± 80.0000.02329 ± 110.0020.00451 ± 120.0110.00468 ± 130.0360.01415
Prednisolone10 ± 60.03129 ± 80.0010.00241 ± 90.0160.00257 ± 110.0480.00015

Abbreviations: Cp, significantly different compared with Control; Gp, significantly different compared with cells cultured in Garlic; n, number of independent experiments.

There was a dose-dependent increase in both Annexin V positive ALL cells and lymphocytes in the presence of all drugs (p < 0.05 for all, Mann Whitney) except lymphocytes in the presence of garlic extract (p = 0.235) (Table 1) compared with control with no drug (dose dependent data not shown). Following culture for 48 hrs, there was a significant increase in Annexin V/7AAD positive lymphocytes and ALL cells in the presence of all drugs compared with control (p < 0.05) except lymphocytes in the presence of garlic extract (p = 0.489) and ajoene (p = 0.380) (Table 1). There was a significant increase in Annexin V/7AAD positive ALL cells in the presence of garlic compared with several drugs. Representative dot plots showing Annexin V FITC and 7-AAD staining of CD34 positive ALL cells and CD34 negative lymphocytes following culture in the presence of 0.1 μg/mL garlic extract for 48 hrs are shown in Figure 1. Almost all CD34 positive ALL cells stain positively for both Annexin V FITC and 7-AAD but very few CD34 negative lymphocytes show signs of apoptosis.
Figure 1

Representative dot plots showing Annexin V FITC and 7-AAD staining of CD34 positive ALL cells and CD34 negative lymphocytes following culture in the presence of 0.1 μg/mL garlic extract for 48 hrs compared with control (Con) (no drug) (gated on CD34 positive ALL cells). Almost all CD34 positive ALL cells stain positively for both Annexin V FITC and 7-AAD in the presence of 0.1 μg/mL garlic extract but very few CD34 negative lymphocytes show signs of apoptosis.

Effect of drugs on lymphocyte activation

At concentrations of garlic compounds that resulted in significant apoptosis of ALL cells but not of T-cells as determined by Annexin V and 7-AAD staining, there was no significant change in CD25 and CD69 upregulation (p > 0.05) (Table 2). In the presence of most drugs, there was a dose-dependent inhibition in CD25 and CD69 upregulation (p < 0.05) (dose-dependent data not shown). The inhibition of these cytokines was significantly greater in the presence of most drugs compared with garlic compounds. Representative dot plots showing CD25 FITC and CD69 PE staining of CD3 positive T cells in the presence of 0.1 μg/mL garlic extract and 2 μg/mL daunorubicin, compared with control without drugs following culture with 10 μg/mL PHA for 24 hrs are shown in Figure 2. There was a significant decrease in both CD25 and CD69 in the presence of daunorubicin (p < 0.05) but not garlic extract compared with control with no drugs.
Table 2

The percentage of CD25 positive, CD69 positive, CD3 positive lymphocytes (mean ± sd) following culture in the presence of no drugs (Control), 2 μg/mL daunorubicin, 50 μg/mL vincristine, 10 IU/mL L-asparaginase, 250 μg/mL prednisolone, 0.1 μg/mL garlic extract, 0.01 μg/mL ajoene, 0.005 μg/mL allitridium compared with normal healthy control subjects

CD3+ Lymphocytes
CD25CpGpCD69CpGpn
Normal85 ± 898 ± 1212
Control75 ± 10#90 ± 1215
Garlic79 ± 891 ± 1415
Ajoene78 ± 789 ± 1315
Allitrid81 ± 890 ± 1415
Daunorubicin28 ± 90.0000.00024 ± 170.0000.00015
Vincristine26 ± 110.0000.00025 ± 150.0000.00015
L-asparaginase49 ± 60.0000.00056 ± 110.0000.00015
Prednisolone52 ± 60.0310.02168 ± 80.0090.00915

Abbreviations:#, significantly different compared with Normal (P , 0.048); Cp, significantly different compared with Control; Gp, significantly different compared with cells cultured in Garlic; n, number of independent experiments.

Figure 2

Representative dot plots showing CD25 FITC and CD69 PE staining of CD3 positive T cells in the presence of (A) 0.1 μg/mL garlic extract and (B) 2 μg/mL daunorubicin, compared with (C) Control, following culture with 10 μg/mL PHA for 24 hrs. There was a significant decrease in both CD25 and CD69 in the presence of daunorubicin (p < 0.05) but not garlic extract compared with control(C).

Effect of drugs on lymphocyte cytokine production

At concentrations of garlic compounds that resulted in significant apoptosis of ALL cells but not of T-cells as determined by Annexin V and 7-AAD staining, there was no significant change in intracellular interferonγ (IFNγ), interleukin-2 (IL-2), or tumor necrosis factor-α (TNFα) production (Table 3). In the presence of most drugs, there was a dose-dependent inhibition in intracellular IFNγ, IL-2, TNFα production (p < 0.05). The dose-dependent inhibition of IFNγ by drugs is shown in Figure 3 (dose-dependent data for IL-2 and TNFα not shown). The inhibition of these cytokines was significantly greater in the presence of most drugs compared with garlic compounds. Representative dot plots showing intracellular CD8+ and CD8− (CD4+) T-cell production of IFNγ, IL-2 and TNFα in the presence of 0.1 μg/mL garlic extract and 50 μg/mL vincristine from PBMC from a patient with ALL compared with an aged-matched control with no drugs is shown in Figure 4. The percentage and mean fluorescence intensity of CD8+ and CD8− (CD4+) T-cells producing IFNγ, IL-2, and TNFα was significantly inhibited (p < 0.05) in the presence of vincristine but not garlic extract (p < 0.05) compared with control without drugs (data not shown). Intracellular CD8+ and CD8− (CD4+) T-cell production of IFNγ, IL-2, and TNFα by PBMC from the ALL patient was significantly decreased (p < 0.05) compared with the healthy age-matched control.
Table 3

The percentage of cytokine positive CD3 positive lymphocytes (mean ± SD) following culture in the presence of no drugs (Control), 2 μg/mL daunorubicin, 50 μg/mL vincristine, 10 IU/mL L-asparaginase, 250 μg/mL prednisolone, 0.1 μg/mL garlic extract, 0.01 μg/mL ajoene, 0.005 μg/mL allitridium compared with control subjects (n = 12)

CD3+ Lymphocytes
IFNCpGpIL-2CpGpTNFαCpGpn
Normal61 ± 641 ± 545 ± 812
Control22 ± 5#14 ± 4#24 ± 6#15
Garlic25 ± 417 ± 527 ± 515
Ajoene24 ± 516 ± 326 ± 415
Allitrid23 ± 615 ± 627 ± 715
Daunorubicin12 ± 60.0370.0312 ± 20.0000.00013 ± 70.0310.02615
Vincristine14 ± 70.0410.0353 ± 20.0000.00016 ± 80.0400.03515
L-asparaginase18 ± 87 ± 50.0330.02519 ± 60.0490.04015
Prednisolone21 ± 810 ± 522 ± 515

Abbreviations:#, significantly different compared with Normal (p < 0.000, p < 0.000, p < 0.003 for IFNg, IL-2, and TNFa, respectively); Cp, significantly different compared with Control; Gp, significantly different compared with cells cultured in Garlic; n, number of independent experiments.

Figure 3

Graph showing dose-dependent inhibition of T-cell IFNγ production in the presence of increasing concentrations of D: daunorubicin (0.002, 0.02, 0.2, 2.0, 20 μg/mL), V: vincritine (0.005, 0.05, 0.5, 5, 50 μg/mL), Al: allitridium (0.0002, 0.005, 0.02, 0.2, 2.5 μg/mL), L: L-asparaginase (0.003, 0.03, 0.3, 3, 10 μg/mL), Aj: ajoene (0.0005, 0.005, 0.01, 0.5, 5 μg/mL), G: garlic extract (0.001, 0.01, 0.1, 1, 10 μg/mL) and P: Prednisolone (0.08, 0.8, 8, 80, 250 μg/mL).

Figure 4

Representative dot plots showing intracellular CD8+ and CD8− (CD4+) T-cell production of IFNγ, IL-2 and TNFα in the presence of (A) 0.1 μg/mL garlic extract and (B) 50 μg/mL vincristine from PBMC from a patient with ALL compared with healthy aged-matched control subject (C). The percentage and mean fluorescence intenstiy of CD8+ and CD8− (CD4+) T-cell producing IFNγ, IL-2, and TNFα was significantly inhibited (p < 0.05) in the presence of vincristine but not garlic extract (p > 0.05) compared with control without drugs (data not shown). Intracellular CD8+ and CD8− (CD4+) T-cell production of IFNγ, IL-2, and TNFα by PBMC from the ALL patient was significantly decreased (p < 0.05) compared with control.

Discussion

We report selective apoptosis of malignant cells by garlic compounds that do not alter lymphocyte viability or T-cell immune function in vitro. Drugs used for remission induction therapy for childhood pre-B ALL have been shown to be nonselective in targeting only malignant cells and result in loss of hemopoietic cells (Leussink et al 2001) and our current studies confirm these findings. Our findings regarding the apoptotic effect of currently used chemotherapeutic drugs on childhood pre-B ALL cells are consistent with a recent report (Holleman et al 2003). We now show that the presence of these drugs result in a rapid transition of CD34 positive ALL cells from early (Annexin V+/7AAD−) to late apoptosis (Annexin V+/7AAD+). However, there have been reports of CD34 negative leukemic stem cells being resistant to current therapeutic strategies and that subsequent relapses may arise from this population (Cox and Blair 2005). Further studies into the effect of garlic compounds and current chemotherapeutic drugs on this small leukemic stem cell population are required once more precise definition of this subset is available. T-helper-type 1 (Th1) responses are important in immune response against malignant cells, viruses and microbial infections. T-cell immune function has been shown to be impaired in children with ALL before and during treatment (Nash et al 1993). A previous study showed that intracellular T-cell IFNγ and IL-2 production was impaired in children with ALL (Nash et al 1993) and our current findings of reduced intracellular T-cell IFNγ and IL-2 by the majority of these patients confirms these previous findings. Our additional findings of impaired T-cell TNFα production are important as TNFα has been shown to inhibit tumor cell growth in a variety of hematological malignancies (Reed and Pellechia 2005) and stimulate immune response to tumors (Vassalli 1992). Our current findings show that children with ALL have an impaired Th1 response at presentation and are subsequently treated with drugs that further impair the antileukemic immune response. Not surprisingly, we have previously shown that apoptotic cells have an impaired capacity for Th1 cytokine production (Hodge et al 2000). In contrast, the presence of garlic compounds did not impair T-cell proliferation or Th1 responses by T cells from children with ALL or normal healthy controls. Patients with childhood ALL are susceptible to a variety of bacterial, fungal, and viral infections. Garlic compounds have been shown to have antimicrobial properties in the prevention and treatment of common infective organisms in these patients such as methicillin-resistant Staphylococcus aureus (Cutler and Wilson 2004), Escherichia coli (Sasaki et al 1999), Aspergillus spp. (Shadkchan et al 2004), and invasive fungal infections (Davis 2005) and the mechanism of action of garlic has recently been described (Davis 2005). Garlic compounds have also been shown to be effective in the clinic against CMV, a common pathogen isolated from these patients (Lu 1994). The intravenous use of garlic compounds in the treatment of invasive fungal infections in humans has been shown to be safe and effective (Davis 2003) and anti-fungal activity has been shown in human serum and urine after ingestion of garlic (Caporaso et al 1983) suggesting either form of therapy for the treatment of childhood ALL may be effective. Further investigations are warranted into the dose of garlic extracts, both oral and intravenous, required to achieve efficacy in the treatment of childhood ALL. After oral consumption or intravenous dose of garlic extracts to volunteers, serum from these volunteers could be substituted in similar experiments to that described in this manuscript to determine optimal dosage to achieve maximal killing of ALL cells while maintaining Th1 response. Previous findings taken together with our current investigations argue for the use of garlic compounds in the therapeutic treatment of childhood pre-B ALL to selectively kill ALL cells and prevent morbidity associated with pathogenic microbial organisms while maintaining cellular immune function.
  21 in total

Review 1.  An overview of the antifungal properties of allicin and its breakdown products--the possibility of a safe and effective antifungal prophylactic.

Authors:  Stephen R Davis
Journal:  Mycoses       Date:  2005-03       Impact factor: 4.377

2.  Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation.

Authors:  S Hodge; G Hodge; M Holmes; P N Reynolds
Journal:  Eur Respir J       Date:  2005-03       Impact factor: 16.671

Review 3.  Apoptosis-based therapies for hematologic malignancies.

Authors:  John C Reed; Maurizio Pellecchia
Journal:  Blood       Date:  2005-03-29       Impact factor: 22.113

Review 4.  Enhanced immunocompetence by garlic: role in bladder cancer and other malignancies.

Authors:  D L Lamm; D R Riggs
Journal:  J Nutr       Date:  2001-03       Impact factor: 4.798

5.  Effect of intermediate-purity factor VIII (FVIII) concentrate on lymphocyte proliferation and apoptosis: transforming growth factor-beta is a significant immunomodulatory component of FVIII.

Authors:  G Hodge; P Han
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

6.  The in vitro susceptibility of Scedosporium prolificans to ajoene, allitridium and a raw extract of garlic (Allium sativum).

Authors:  Stephen R Davis; Rosemary Perrie; Rafael Apitz-Castro
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

7.  T cell function in children with acute lymphoblastic leukaemia.

Authors:  K A Nash; G Mohammed; N Nandapalan; J Kernahan; R Scott; A W Craft; G L Toms
Journal:  Br J Haematol       Date:  1993-03       Impact factor: 6.998

8.  Antibacterial activity of a new, stable, aqueous extract of allicin against methicillin-resistant Staphylococcus aureus.

Authors:  R R Cutler; P Wilson
Journal:  Br J Biomed Sci       Date:  2004       Impact factor: 3.829

9.  Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia.

Authors:  Amy Holleman; Monique L den Boer; Karin M Kazemier; Gritta E Janka-Schaub; Rob Pieters
Journal:  Blood       Date:  2003-08-14       Impact factor: 22.113

10.  Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease.

Authors:  Greg Hodge; Sandy Hodge; Ping Han
Journal:  Cytometry       Date:  2002-08-01
View more
  4 in total

Review 1.  Methods of Isolation of Active Substances from Garlic (Allium sativum L.) and Its Impact on the Composition and Biological Properties of Garlic Extracts.

Authors:  Monika Bar; Urszula E Binduga; Konrad A Szychowski
Journal:  Antioxidants (Basel)       Date:  2022-07-09

2.  Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines.

Authors:  Faten Merhi; Jacques Auger; Francine Rendu; Brigitte Bauvois
Journal:  Biologics       Date:  2008-12

Review 3.  In Vitro and In Vivo Immunomodulator Activities of Allium sativum L.

Authors:  Mouna Moutia; Norddine Habti; Abdallah Badou
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-12       Impact factor: 2.629

Review 4.  Historical ethnobotanical review of medicinal plants used to treat children diseases in Romania (1860s-1970s).

Authors:  Madalina Petran; Dorin Dragos; Marilena Gilca
Journal:  J Ethnobiol Ethnomed       Date:  2020-03-24       Impact factor: 2.733

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.